A 2022 trial measured daily symptom diaries
A 2022 trial measured daily symptom diaries in 96 healthy adults taking 5.2 g of PHGG. This study is a great example of how to understand the specifics of fibre research. The dose of 5.2 g is a key piece of information, as it tells us exactly how much of the ingredient was used in the study.
Study doses and blend percentages are different numbers
Study doses and blend percentages are often confused, but they are different numbers. For example, PHGG is 32% of the BIOMEWARD blend, but the 2022 trial tested the ingredient at a dose of 5.2 g, not the finished product. This distinction is crucial when interpreting the results of fibre studies.
Interpreting fibre studies like a sceptic
To interpret fibre studies like a sceptic, it's essential to pay attention to the specifics of the study, including the dose and blend percentage. A study that tests an ingredient at a certain dose may not necessarily reflect the effects of a finished product that contains that ingredient at a different percentage. By carefully reading the study details, you can make more informed decisions about the research.
Practical application
In practice, this means that when reading a fibre study, you should look for the specific dose used in the study, as well as the blend percentage of the ingredient being tested. By doing so, you can better understand the results and how they relate to the finished product. For example, if a study used 5.2 g of PHGG, you should not assume that the same effects would be seen with a different dose or blend percentage, such as the 32% PHGG in the BIOMEWARD blend.